Sjögren syndrome
2016 · Nature Reviews Disease Primers · 801 citations
https://doi.org/10.1038/nrdp.2016.47
C
Chiara Baldini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
481
Papers
10.4K
Citations
52
h-index
176
i10-index
Chiara Baldini is an academic researcher from University of Pisa. The author has contributed to research in topics: Salivary Gland Disorders and Functions & Salivary Gland Tumors Diagnosis and Treatment & Systemic Sclerosis and Related Diseases. The author has an h-index of 52, co-authored 409 publications.
ORCID: 0000-0002-4454-1824Papers by this author
worksMepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
2021 · Arthritis & Rheumatology · 153 citations
https://doi.org/10.1002/art.41943
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
2022 · JCI Insight · 108 citations
https://doi.org/10.1172/jci.insight.163030
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
2015 · Arthritis Research & Therapy · 69 citations
https://doi.org/10.1186/s13075-015-0790-3
CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
2024 · Nature Medicine · 50 citations
https://doi.org/10.1038/s41591-024-03009-3
Sjögren’s syndrome: state of the art on clinical practice guidelines
2018 · RMD Open · 48 citations
https://doi.org/10.1136/rmdopen-2018-000789
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat